Rank | Gene Set | Z-score |
---|---|---|
1 | chemical homeostasis within a tissue (GO:0048875) | 9.41514897 |
2 | vitamin transmembrane transport (GO:0035461) | 7.12602918 |
3 | intestinal epithelial cell development (GO:0060576) | 6.80772806 |
4 | positive regulation by symbiont of host defense response (GO:0052509) | 5.79436857 |
5 | modulation by symbiont of host defense response (GO:0052031) | 5.79436857 |
6 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.79436857 |
7 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.79436857 |
8 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.79436857 |
9 | modulation by symbiont of host immune response (GO:0052553) | 5.79436857 |
10 | detection of molecule of bacterial origin (GO:0032490) | 5.44713261 |
11 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.20458695 |
12 | cellular extravasation (GO:0045123) | 5.13026812 |
13 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.00942668 |
14 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338) | 4.96607882 |
15 | lung-associated mesenchyme development (GO:0060484) | 4.91068520 |
16 | response to xenobiotic stimulus (GO:0009410) | 4.81328327 |
17 | leukocyte migration involved in inflammatory response (GO:0002523) | 4.80637517 |
18 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.78482025 |
19 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.74874161 |
20 | negative regulation of cell killing (GO:0031342) | 4.74874161 |
21 | neutrophil activation involved in immune response (GO:0002283) | 4.62827525 |
22 | cellular response to nitric oxide (GO:0071732) | 4.60911500 |
23 | macrophage activation involved in immune response (GO:0002281) | 4.51567481 |
24 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 4.50698720 |
25 | detection of other organism (GO:0098543) | 4.50190880 |
26 | detection of external biotic stimulus (GO:0098581) | 4.49130421 |
27 | microglial cell activation (GO:0001774) | 4.44684309 |
28 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 4.42952836 |
29 | pattern specification involved in kidney development (GO:0061004) | 4.33169316 |
30 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 4.31155681 |
31 | response to host immune response (GO:0052572) | 4.27748232 |
32 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 4.27748232 |
33 | purine nucleobase biosynthetic process (GO:0009113) | 4.24853118 |
34 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 4.21107287 |
35 | branching involved in prostate gland morphogenesis (GO:0060442) | 4.18123427 |
36 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.18081593 |
37 | mitotic metaphase plate congression (GO:0007080) | 4.10896655 |
38 | response to interleukin-15 (GO:0070672) | 4.10481292 |
39 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 4.03125254 |
40 | tight junction assembly (GO:0070830) | 4.02977322 |
41 | regulation of gamma-delta T cell activation (GO:0046643) | 4.00338763 |
42 | regulation of hippo signaling (GO:0035330) | 3.97120813 |
43 | detection of biotic stimulus (GO:0009595) | 3.94455829 |
44 | neutrophil activation (GO:0042119) | 3.93728303 |
45 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.92279806 |
46 | response to host (GO:0075136) | 3.92279806 |
47 | response to host defenses (GO:0052200) | 3.92279806 |
48 | lung lobe morphogenesis (GO:0060463) | 3.91652537 |
49 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.90800501 |
50 | response to peptidoglycan (GO:0032494) | 3.87935293 |
51 | negative regulation of B cell mediated immunity (GO:0002713) | 3.87289376 |
52 | negative regulation of immunoglobulin mediated immune response (GO:0002890) | 3.87289376 |
53 | neutrophil mediated immunity (GO:0002446) | 3.87184521 |
54 | detection of bacterium (GO:0016045) | 3.87003038 |
55 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.85366820 |
56 | sphingosine metabolic process (GO:0006670) | 3.84190381 |
57 | leukocyte aggregation (GO:0070486) | 3.80568479 |
58 | macrophage activation (GO:0042116) | 3.80562489 |
59 | cellular response to reactive nitrogen species (GO:1902170) | 3.74187941 |
60 | negative regulation of fibroblast apoptotic process (GO:2000270) | 3.72672408 |
61 | pantothenate metabolic process (GO:0015939) | 3.71362310 |
62 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.69423820 |
63 | prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis (GO:006052 | 3.67632777 |
64 | respiratory burst (GO:0045730) | 3.67465403 |
65 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.66894701 |
66 | negative regulation of protein activation cascade (GO:2000258) | 3.63626865 |
67 | regulation of attachment of spindle microtubules to kinetochore (GO:0051988) | 3.61945739 |
68 | peptide catabolic process (GO:0043171) | 3.60003357 |
69 | regulation of spindle organization (GO:0090224) | 3.59077418 |
70 | negative regulation of complement activation (GO:0045916) | 3.58184035 |
71 | modified amino acid transport (GO:0072337) | 3.54021543 |
72 | negative regulation of humoral immune response (GO:0002921) | 3.52816867 |
73 | pyrimidine-containing compound transmembrane transport (GO:0072531) | 3.52704189 |
74 | diol metabolic process (GO:0034311) | 3.51641248 |
75 | lung secretory cell differentiation (GO:0061140) | 3.48614210 |
76 | cellular response to interleukin-15 (GO:0071350) | 3.47977236 |
77 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.47717881 |
78 | sulfur compound transport (GO:0072348) | 3.45865409 |
79 | vitamin transport (GO:0051180) | 3.44304729 |
80 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.43023117 |
81 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 3.42911980 |
82 | folic acid metabolic process (GO:0046655) | 3.42466564 |
83 | folic acid transport (GO:0015884) | 3.41280154 |
84 | granulocyte activation (GO:0036230) | 3.40140857 |
85 | ectodermal placode formation (GO:0060788) | 3.38386332 |
86 | response to nitric oxide (GO:0071731) | 3.37988543 |
87 | one-carbon compound transport (GO:0019755) | 3.37636285 |
88 | trivalent inorganic anion homeostasis (GO:0072506) | 3.35726083 |
89 | phosphate ion homeostasis (GO:0055062) | 3.35726083 |
90 | cysteine metabolic process (GO:0006534) | 3.35097503 |
91 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 3.32996485 |
92 | myeloid leukocyte mediated immunity (GO:0002444) | 3.31833152 |
93 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.30170677 |
94 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 3.29205523 |
95 | nucleobase biosynthetic process (GO:0046112) | 3.28729868 |
96 | response to mercury ion (GO:0046689) | 3.26658094 |
97 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class | 3.25542861 |
98 | dichotomous subdivision of an epithelial terminal unit (GO:0060600) | 3.24946149 |
99 | myeloid cell activation involved in immune response (GO:0002275) | 3.23711573 |
100 | negative regulation of interleukin-12 production (GO:0032695) | 3.22026501 |
101 | B cell receptor signaling pathway (GO:0050853) | 3.20571759 |
102 | ribosome assembly (GO:0042255) | 3.19329871 |
103 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.13895136 |
104 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.13363190 |
105 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.11531802 |
106 | regulation of protein activation cascade (GO:2000257) | 3.09863927 |
107 | regulation of complement activation (GO:0030449) | 3.08896385 |
108 | nucleotide-sugar biosynthetic process (GO:0009226) | 3.08893869 |
109 | anterior/posterior axis specification, embryo (GO:0008595) | 3.07434158 |
110 | sphingoid metabolic process (GO:0046519) | 3.07420335 |
111 | negative regulation of transcription by competitive promoter binding (GO:0010944) | 3.07189076 |
112 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 3.05286322 |
113 | spindle assembly involved in mitosis (GO:0090307) | 3.04526882 |
114 | regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator | 3.03731248 |
115 | establishment of apical/basal cell polarity (GO:0035089) | 3.01541693 |
116 | CDP-diacylglycerol metabolic process (GO:0046341) | 3.00364272 |
117 | positive regulation of chromosome segregation (GO:0051984) | 2.99620778 |
118 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.99148068 |
119 | regulation of B cell differentiation (GO:0045577) | 2.98222341 |
120 | response to nitrosative stress (GO:0051409) | 2.97644961 |
121 | negative regulation of B cell proliferation (GO:0030889) | 2.97615008 |
122 | positive regulation of mast cell activation (GO:0033005) | 2.97261923 |
123 | neutrophil migration (GO:1990266) | 2.96630303 |
124 | xenobiotic catabolic process (GO:0042178) | 2.96412046 |
125 | DNA damage response, signal transduction resulting in transcription (GO:0042772) | 2.95028588 |
126 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.93959207 |
127 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.93800839 |
128 | regulation of G0 to G1 transition (GO:0070316) | 2.92379232 |
129 | positive regulation of interferon-alpha production (GO:0032727) | 2.92350368 |
130 | dendritic cell migration (GO:0036336) | 2.91574641 |
131 | metaphase plate congression (GO:0051310) | 2.91032915 |
132 | phosphate ion transmembrane transport (GO:0035435) | 2.90967828 |
133 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 2.90602991 |
134 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 2.90602991 |
135 | regulation of mast cell degranulation (GO:0043304) | 2.90315270 |
136 | negative regulation of T cell mediated immunity (GO:0002710) | 2.89942702 |
137 | negative regulation of adaptive immune response (GO:0002820) | 2.89855311 |
138 | positive regulation of B cell differentiation (GO:0045579) | 2.87988035 |
139 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.86106382 |
140 | neutrophil chemotaxis (GO:0030593) | 2.84862623 |
141 | negative regulation of fibrinolysis (GO:0051918) | 2.84533285 |
142 | epithelial cell maturation (GO:0002070) | 2.84494335 |
143 | regulation of mast cell activation (GO:0033003) | 2.83942387 |
144 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.82872261 |
145 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.82872261 |
146 | negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254) | 2.82446416 |
147 | positive regulation of endothelial cell differentiation (GO:0045603) | 2.82316748 |
148 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.80296588 |
149 | replicative senescence (GO:0090399) | 2.79923247 |
150 | hepatocyte apoptotic process (GO:0097284) | 2.79155961 |
151 | columnar/cuboidal epithelial cell development (GO:0002066) | 2.78093062 |
152 | positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:00360 | 2.77950698 |
153 | branching involved in labyrinthine layer morphogenesis (GO:0060670) | 2.76798672 |
154 | cell wall macromolecule catabolic process (GO:0016998) | 2.76057145 |
155 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.75824053 |
156 | response to interleukin-6 (GO:0070741) | 2.74637699 |
157 | regulation of translation in response to stress (GO:0043555) | 2.74275494 |
158 | immunoglobulin mediated immune response (GO:0016064) | 2.73042510 |
159 | polyol transport (GO:0015791) | 2.72168592 |
160 | superoxide anion generation (GO:0042554) | 2.71971244 |
161 | negative regulation of Ras GTPase activity (GO:0034261) | 2.71872931 |
162 | prostate gland epithelium morphogenesis (GO:0060740) | 2.71550647 |
163 | plasma lipoprotein particle assembly (GO:0034377) | 2.71402029 |
164 | very-low-density lipoprotein particle assembly (GO:0034379) | 2.68566221 |
165 | regulation of mitotic spindle organization (GO:0060236) | 2.68219820 |
166 | regulation of receptor binding (GO:1900120) | 2.68170271 |
167 | regulation of branching involved in prostate gland morphogenesis (GO:0060687) | 2.67885048 |
168 | regulation of tolerance induction (GO:0002643) | 2.67564368 |
169 | hormone catabolic process (GO:0042447) | 2.66893069 |
170 | establishment or maintenance of monopolar cell polarity (GO:0061339) | 2.65662934 |
171 | establishment of monopolar cell polarity (GO:0061162) | 2.65662934 |
172 | myeloid leukocyte activation (GO:0002274) | 2.64703630 |
173 | leukocyte degranulation (GO:0043299) | 2.63664388 |
174 | sulfur amino acid catabolic process (GO:0000098) | 2.63031346 |
175 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.62542307 |
176 | regulation of histone H3-K27 methylation (GO:0061085) | 2.62392997 |
177 | regulation of interferon-alpha production (GO:0032647) | 2.62304444 |
178 | microtubule cytoskeleton organization involved in mitosis (GO:1902850) | 2.62024947 |
179 | epithelial tube branching involved in lung morphogenesis (GO:0060441) | 2.61937445 |
180 | DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 cla | 2.61716371 |
181 | autophagic vacuole assembly (GO:0000045) | 2.61089722 |
182 | sequestering of metal ion (GO:0051238) | 2.60889515 |
183 | negative regulation of fatty acid transport (GO:2000192) | 2.60484080 |
184 | centrosome localization (GO:0051642) | 2.59822862 |
185 | regulation of establishment or maintenance of cell polarity (GO:0032878) | 2.58991002 |
186 | mannose metabolic process (GO:0006013) | 2.58749132 |
187 | regulation of cell-cell adhesion mediated by cadherin (GO:2000047) | 2.57284770 |
188 | ectoderm development (GO:0007398) | 2.56918262 |
189 | artery development (GO:0060840) | 2.56035903 |
190 | cellular anion homeostasis (GO:0030002) | 2.55669410 |
191 | protein localization to endosome (GO:0036010) | 2.54199559 |
192 | regulation of establishment of cell polarity (GO:2000114) | 2.54044951 |
193 | blastocyst development (GO:0001824) | 2.52890322 |
194 | S-adenosylmethionine metabolic process (GO:0046500) | 2.52401678 |
195 | segment specification (GO:0007379) | 2.51815591 |
196 | phosphate ion transport (GO:0006817) | 2.51226794 |
197 | CDP-diacylglycerol biosynthetic process (GO:0016024) | 2.50735527 |
198 | regulation of phospholipid biosynthetic process (GO:0071071) | 2.50023308 |
199 | positive regulation of autophagy (GO:0010508) | 2.48623349 |
200 | surfactant homeostasis (GO:0043129) | 11.3435714 |
Rank | Gene Set | Z-score |
---|---|---|
1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.32292477 |
2 | AR_21909140_ChIP-Seq_LNCAP_Human | 4.03334135 |
3 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.96979657 |
4 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 3.80888016 |
5 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.76701451 |
6 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.63584321 |
7 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 3.62664613 |
8 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 3.41344199 |
9 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.32718331 |
10 | ZNF263_19887448_ChIP-Seq_K562_Human | 3.29017989 |
11 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 3.12857806 |
12 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.07754692 |
13 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.01216358 |
14 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.97971832 |
15 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.94896617 |
16 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.86219879 |
17 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.85250247 |
18 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.80606511 |
19 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.78214195 |
20 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.77843135 |
21 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 2.73548295 |
22 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.73236910 |
23 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.69789602 |
24 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.68990657 |
25 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 2.63312903 |
26 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.60826071 |
27 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.58265689 |
28 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 2.50868167 |
29 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 2.50868167 |
30 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 2.50868167 |
31 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 2.46768019 |
32 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 2.46650252 |
33 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.43243685 |
34 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 2.40752688 |
35 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 2.27510093 |
36 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.25149229 |
37 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.24589915 |
38 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.21869511 |
39 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.20355751 |
40 | MYB_26560356_Chip-Seq_TH2_Human | 2.19714337 |
41 | VDR_24787735_ChIP-Seq_THP-1_Human | 2.18286292 |
42 | * NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 2.17256690 |
43 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 2.11342378 |
44 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.10313530 |
45 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.08339754 |
46 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 2.07985480 |
47 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.03189481 |
48 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 2.02779647 |
49 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.02087922 |
50 | GATA4_25053715_ChIP-Seq_YYC3_Human | 2.01420033 |
51 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.98897140 |
52 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.98364334 |
53 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.97032115 |
54 | SPI1_23127762_ChIP-Seq_K562_Human | 1.91256837 |
55 | * SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.88109019 |
56 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.87536876 |
57 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.86151593 |
58 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.81703642 |
59 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.79399941 |
60 | MYB_26560356_Chip-Seq_TH1_Human | 1.72413596 |
61 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.69850049 |
62 | * AHR_22903824_ChIP-Seq_MCF-7_Human | 1.67926896 |
63 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.63594078 |
64 | GATA3_26560356_Chip-Seq_TH2_Human | 1.62483366 |
65 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.61912482 |
66 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.60321343 |
67 | * FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.59269848 |
68 | NANOG_18358816_ChIP-ChIP_MESCs_Mouse | 1.58123845 |
69 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.55415712 |
70 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.55267911 |
71 | NANOG_18347094_ChIP-ChIP_MESCs_Mouse | 1.55044402 |
72 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.54712074 |
73 | GATA1_22025678_ChIP-Seq_K562_Human | 1.54373308 |
74 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.54091466 |
75 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.52571888 |
76 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.51562296 |
77 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.49690782 |
78 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 1.49570705 |
79 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.49018624 |
80 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.48524051 |
81 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.47423805 |
82 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.45292215 |
83 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.42312873 |
84 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.41634994 |
85 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.40792166 |
86 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.39840743 |
87 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.38688498 |
88 | * ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.38189767 |
89 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.37718113 |
90 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.37687668 |
91 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.37369746 |
92 | * TCFCP2L1_18555785_ChIP-Seq_MESCs_Mouse | 1.37362583 |
93 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.36535028 |
94 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.36079918 |
95 | CHD1_26751641_Chip-Seq_LNCaP_Human | 1.35277346 |
96 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.33659943 |
97 | NANOG_18692474_ChIP-Seq_MEFs_Mouse | 1.33417009 |
98 | TCF3_18692474_ChIP-Seq_MESCs_Mouse | 1.32866274 |
99 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.32094730 |
100 | * SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 1.30795207 |
101 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.30069073 |
102 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.29300435 |
103 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.29291837 |
104 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.29167563 |
105 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 1.28873941 |
106 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.27030978 |
107 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 1.26385639 |
108 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.25507107 |
109 | TCF3_18347094_ChIP-ChIP_MESCs_Mouse | 1.24732288 |
110 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.23810295 |
111 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.23646991 |
112 | KAP1_27257070_Chip-Seq_ESCs_Mouse | 1.23153628 |
113 | * NANOG_18692474_ChIP-Seq_MESCs_Mouse | 1.23130566 |
114 | * E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.21853037 |
115 | * KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.20631401 |
116 | SOX2_19030024_ChIP-ChIP_MESCs_Mouse | 1.20566275 |
117 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.20555556 |
118 | ATF3_27146783_Chip-Seq_COLON_Human | 1.20389427 |
119 | * SOX2_18555785_ChIP-Seq_MESCs_Mouse | 1.19037068 |
120 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.19026861 |
121 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.16943583 |
122 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.16943583 |
123 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.15173517 |
124 | MAF_26560356_Chip-Seq_TH1_Human | 1.15096777 |
125 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.14736808 |
126 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.14216117 |
127 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 1.14053049 |
128 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.13437127 |
129 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.13220078 |
130 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.12205730 |
131 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.11995194 |
132 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.11957577 |
133 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.11028633 |
134 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.10709313 |
135 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.09970948 |
136 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.09887239 |
137 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.09169409 |
138 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.09039562 |
139 | * SOX2_18692474_ChIP-Seq_MESCs_Mouse | 1.08935308 |
140 | KLF5_25053715_ChIP-Seq_YYC3_Human | 1.08787472 |
141 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.08721862 |
142 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.08448810 |
143 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.08157810 |
144 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.07994680 |
145 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.06995952 |
146 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.06785753 |
147 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.06669540 |
148 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.06621407 |
149 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.06010271 |
150 | * ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.05633148 |
151 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.05066368 |
152 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.04772024 |
153 | * NANOG_21062744_ChIP-ChIP_HESCs_Human | 1.04572859 |
154 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.02974904 |
155 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.02504514 |
156 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.02242306 |
157 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.01458267 |
158 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 1.01279548 |
159 | PRDM14_21183938_ChIP-Seq_MESCs_Mouse | 1.01050775 |
160 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.00601548 |
161 | UTX_26944678_Chip-Seq_JUKART_Human | 0.99621952 |
162 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.99402210 |
163 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.99012549 |
164 | * CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.98615654 |
165 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.98372598 |
166 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.96564656 |
167 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.96480067 |
168 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.96354446 |
169 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.95645472 |
170 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.95501415 |
171 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.95133962 |
172 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.93324849 |
173 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.91557952 |
174 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.91439632 |
175 | GATA2_19941826_ChIP-Seq_K562_Human | 0.91411353 |
176 | * EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.89978047 |
177 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.88490064 |
178 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.88229604 |
179 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.88229604 |
180 | * PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.88173008 |
181 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.86634137 |
182 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.86315976 |
183 | * SALL4_22934838_ChIP-ChIP_CD34+_Human | 0.85985481 |
184 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.85892951 |
185 | * NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.84863537 |
186 | GATA3_26560356_Chip-Seq_TH1_Human | 0.84398951 |
187 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.82996962 |
188 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.82783279 |
189 | * SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.80965128 |
190 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.80836607 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0004782_abnormal_surfactant_physiolog | 6.92773012 |
2 | MP0003724_increased_susceptibility_to | 4.50588514 |
3 | MP0003195_calcinosis | 4.10162729 |
4 | MP0008995_early_reproductive_senescence | 3.87587290 |
5 | MP0001958_emphysema | 3.81230422 |
6 | MP0010234_abnormal_vibrissa_follicle | 3.80303742 |
7 | MP0003693_abnormal_embryo_hatching | 3.56049870 |
8 | MP0005377_hearing/vestibular/ear_phenot | 3.15281264 |
9 | MP0003878_abnormal_ear_physiology | 3.15281264 |
10 | MP0003436_decreased_susceptibility_to | 2.90214657 |
11 | MP0001835_abnormal_antigen_presentation | 2.74041611 |
12 | MP0004264_abnormal_extraembryonic_tissu | 2.70018687 |
13 | MP0003718_maternal_effect | 2.67518591 |
14 | MP0003303_peritoneal_inflammation | 2.63258263 |
15 | MP0002419_abnormal_innate_immunity | 2.58024826 |
16 | MP0008004_abnormal_stomach_pH | 2.57881789 |
17 | MP0000537_abnormal_urethra_morphology | 2.48330922 |
18 | MP0003172_abnormal_lysosome_physiology | 2.45493462 |
19 | MP0003786_premature_aging | 2.33542461 |
20 | MP0008260_abnormal_autophagy | 2.32335025 |
21 | MP0005025_abnormal_response_to | 2.26982944 |
22 | MP0003252_abnormal_bile_duct | 2.25695292 |
23 | MP0009785_altered_susceptibility_to | 2.24788123 |
24 | MP0001800_abnormal_humoral_immune | 2.23226256 |
25 | MP0002132_abnormal_respiratory_system | 2.21092264 |
26 | MP0001177_atelectasis | 2.20554685 |
27 | MP0002139_abnormal_hepatobiliary_system | 2.18222593 |
28 | MP0000569_abnormal_digit_pigmentation | 2.17573294 |
29 | MP0005671_abnormal_response_to | 2.17294084 |
30 | MP0008789_abnormal_olfactory_epithelium | 2.07706757 |
31 | MP0005464_abnormal_platelet_physiology | 2.06643671 |
32 | MP0005085_abnormal_gallbladder_physiolo | 2.04951173 |
33 | MP0006082_CNS_inflammation | 2.04164459 |
34 | MP0005388_respiratory_system_phenotype | 2.03077734 |
35 | MP0002133_abnormal_respiratory_system | 2.03077734 |
36 | MP0003300_gastrointestinal_ulcer | 2.02596744 |
37 | MP0002277_abnormal_respiratory_mucosa | 1.97387696 |
38 | MP0002723_abnormal_immune_serum | 1.93385240 |
39 | MP0005365_abnormal_bile_salt | 1.93132044 |
40 | MP0004883_abnormal_blood_vessel | 1.89760023 |
41 | MP0005000_abnormal_immune_tolerance | 1.86934859 |
42 | MP0000685_abnormal_immune_system | 1.86168687 |
43 | MP0002452_abnormal_antigen_presenting | 1.84363718 |
44 | MP0010678_abnormal_skin_adnexa | 1.84322503 |
45 | MP0000566_synostosis | 1.83940371 |
46 | MP0002420_abnormal_adaptive_immunity | 1.83181940 |
47 | MP0005310_abnormal_salivary_gland | 1.81537018 |
48 | MP0001819_abnormal_immune_cell | 1.81486429 |
49 | MP0001790_abnormal_immune_system | 1.80967631 |
50 | MP0005387_immune_system_phenotype | 1.80967631 |
51 | MP0005394_taste/olfaction_phenotype | 1.75765012 |
52 | MP0005499_abnormal_olfactory_system | 1.75765012 |
53 | MP0002405_respiratory_system_inflammati | 1.68721193 |
54 | MP0005451_abnormal_body_composition | 1.58144105 |
55 | MP0003111_abnormal_nucleus_morphology | 1.56675986 |
56 | MP0002396_abnormal_hematopoietic_system | 1.56176209 |
57 | MP0005360_urolithiasis | 1.54032893 |
58 | MP0003763_abnormal_thymus_physiology | 1.53917420 |
59 | MP0010030_abnormal_orbit_morphology | 1.53869018 |
60 | MP0004957_abnormal_blastocyst_morpholog | 1.53794384 |
61 | MP0002098_abnormal_vibrissa_morphology | 1.53205434 |
62 | MP0004381_abnormal_hair_follicle | 1.52689675 |
63 | MP0001756_abnormal_urination | 1.49663747 |
64 | MP0003656_abnormal_erythrocyte_physiolo | 1.48615831 |
65 | MP0005058_abnormal_lysosome_morphology | 1.48230735 |
66 | MP0005164_abnormal_response_to | 1.46327627 |
67 | MP0002398_abnormal_bone_marrow | 1.44847959 |
68 | MP0001845_abnormal_inflammatory_respons | 1.44353395 |
69 | MP0005647_abnormal_sex_gland | 1.43915882 |
70 | MP0002166_altered_tumor_susceptibility | 1.43802653 |
71 | MP0000534_abnormal_ureter_morphology | 1.43178315 |
72 | MP0000716_abnormal_immune_system | 1.42252258 |
73 | MP0002295_abnormal_pulmonary_circulatio | 1.41628797 |
74 | MP0001533_abnormal_skeleton_physiology | 1.41061630 |
75 | MP0003123_paternal_imprinting | 1.40149792 |
76 | MP0002148_abnormal_hypersensitivity_rea | 1.39522864 |
77 | MP0000689_abnormal_spleen_morphology | 1.39147958 |
78 | MP0000627_abnormal_mammary_gland | 1.33855865 |
79 | MP0002722_abnormal_immune_system | 1.33550022 |
80 | MP0001346_abnormal_lacrimal_gland | 1.33063812 |
81 | MP0008469_abnormal_protein_level | 1.31791883 |
82 | MP0003828_pulmonary_edema | 1.31039348 |
83 | MP0000383_abnormal_hair_follicle | 1.29389295 |
84 | MP0001851_eye_inflammation | 1.23481717 |
85 | MP0001730_embryonic_growth_arrest | 1.21316658 |
86 | MP0001666_abnormal_nutrient_absorption | 1.21037417 |
87 | MP0010329_abnormal_lipoprotein_level | 1.20868923 |
88 | MP0003890_abnormal_embryonic-extraembry | 1.17588742 |
89 | MP0003941_abnormal_skin_development | 1.17060315 |
90 | MP0005367_renal/urinary_system_phenotyp | 1.16438161 |
91 | MP0000516_abnormal_urinary_system | 1.16438161 |
92 | MP0003690_abnormal_glial_cell | 1.15576793 |
93 | MP0005397_hematopoietic_system_phenotyp | 1.14823791 |
94 | MP0001545_abnormal_hematopoietic_system | 1.14823791 |
95 | MP0002429_abnormal_blood_cell | 1.14288824 |
96 | MP0000609_abnormal_liver_physiology | 1.12978941 |
97 | MP0003315_abnormal_perineum_morphology | 1.11427522 |
98 | MP0004885_abnormal_endolymph | 1.10218917 |
99 | MP0009764_decreased_sensitivity_to | 1.09683810 |
100 | MP0000703_abnormal_thymus_morphology | 1.08677905 |
101 | MP0005395_other_phenotype | 1.07516537 |
102 | MP0000858_altered_metastatic_potential | 1.06980052 |
103 | MP0004019_abnormal_vitamin_homeostasis | 1.06891848 |
104 | MP0003866_abnormal_defecation | 1.06789947 |
105 | MP0010155_abnormal_intestine_physiology | 1.04443242 |
106 | MP0005083_abnormal_biliary_tract | 1.04100828 |
107 | MP0008875_abnormal_xenobiotic_pharmacok | 1.03963801 |
108 | MP0003937_abnormal_limbs/digits/tail_de | 1.02494884 |
109 | MP0000350_abnormal_cell_proliferation | 1.02468784 |
110 | MP0000462_abnormal_digestive_system | 1.01671605 |
111 | MP0002796_impaired_skin_barrier | 1.01601091 |
112 | MP0009333_abnormal_splenocyte_physiolog | 1.01429384 |
113 | MP0003077_abnormal_cell_cycle | 1.00304031 |
114 | MP0000465_gastrointestinal_hemorrhage | 0.99376107 |
115 | MP0010094_abnormal_chromosome_stability | 0.98507416 |
116 | MP0008057_abnormal_DNA_replication | 0.98335701 |
117 | MP0002118_abnormal_lipid_homeostasis | 0.97975152 |
118 | MP0005076_abnormal_cell_differentiation | 0.97952843 |
119 | MP0005408_hypopigmentation | 0.96711274 |
120 | MP0001672_abnormal_embryogenesis/_devel | 0.96682986 |
121 | MP0005380_embryogenesis_phenotype | 0.96682986 |
122 | MP0001293_anophthalmia | 0.95509139 |
123 | MP0002160_abnormal_reproductive_system | 0.94538521 |
124 | MP0002138_abnormal_hepatobiliary_system | 0.94373307 |
125 | MP0002009_preneoplasia | 0.93269364 |
126 | MP0002168_other_aberrant_phenotype | 0.92288630 |
127 | MP0005319_abnormal_enzyme/_coenzyme | 0.92242856 |
128 | MP0000613_abnormal_salivary_gland | 0.91885671 |
129 | MP0009643_abnormal_urine_homeostasis | 0.91305236 |
130 | MP0003011_delayed_dark_adaptation | 0.90940523 |
131 | MP0000681_abnormal_thyroid_gland | 0.90458139 |
132 | MP0005075_abnormal_melanosome_morpholog | 0.90120072 |
133 | MP0001915_intracranial_hemorrhage | 0.89665270 |
134 | MP0000015_abnormal_ear_pigmentation | 0.87820442 |
135 | MP0001919_abnormal_reproductive_system | 0.87813256 |
136 | MP0001542_abnormal_bone_strength | 0.87536332 |
137 | MP0005376_homeostasis/metabolism_phenot | 0.87264345 |
138 | MP0001765_abnormal_ion_homeostasis | 0.87050485 |
139 | MP0005389_reproductive_system_phenotype | 0.86525932 |
140 | MP0002998_abnormal_bone_remodeling | 0.86394828 |
141 | MP0002006_tumorigenesis | 0.85067349 |
142 | MP0000647_abnormal_sebaceous_gland | 0.84833625 |
143 | MP0005187_abnormal_penis_morphology | 0.84534048 |
144 | MP0009840_abnormal_foam_cell | 0.84212636 |
145 | MP0009763_increased_sensitivity_to | 0.84169598 |
146 | MP0003984_embryonic_growth_retardation | 0.83421059 |
147 | MP0000579_abnormal_nail_morphology | 0.83296155 |
148 | MP0002233_abnormal_nose_morphology | 0.82700403 |
149 | MP0000371_diluted_coat_color | 0.82229085 |
150 | MP0001986_abnormal_taste_sensitivity | 0.81843901 |
151 | MP0004947_skin_inflammation | 0.81708737 |
152 | MP0003075_altered_response_to | 0.81130603 |
153 | MP0002136_abnormal_kidney_physiology | 0.80535552 |
154 | MP0005332_abnormal_amino_acid | 0.80058983 |
155 | MP0001485_abnormal_pinna_reflex | 0.79782010 |
156 | MP0002088_abnormal_embryonic_growth/wei | 0.79384514 |
157 | MP0004043_abnormal_pH_regulation | 0.78686736 |
158 | MP0003115_abnormal_respiratory_system | 0.78129766 |
159 | MP0002085_abnormal_embryonic_tissue | 0.77781831 |
160 | MP0003183_abnormal_peptide_metabolism | 0.77636420 |
161 | MP0009278_abnormal_bone_marrow | 0.77271565 |
162 | MP0001175_abnormal_lung_morphology | 0.77071762 |
163 | MP0005636_abnormal_mineral_homeostasis | 0.76930477 |
164 | MP0004484_altered_response_of | 0.76445087 |
165 | MP0000762_abnormal_tongue_morphology | 0.74469165 |
166 | MP0003566_abnormal_cell_adhesion | 0.73897183 |
167 | MP0002086_abnormal_extraembryonic_tissu | 0.73708372 |
168 | MP0000598_abnormal_liver_morphology | 0.72906579 |
169 | MP0003119_abnormal_digestive_system | 0.72819581 |
170 | MP0003221_abnormal_cardiomyocyte_apopto | 0.72626975 |
171 | MP0003191_abnormal_cellular_cholesterol | 0.72091235 |
172 | MP0002084_abnormal_developmental_patter | 0.71787492 |
173 | MP0002877_abnormal_melanocyte_morpholog | 0.71533986 |
174 | MP0003186_abnormal_redox_activity | 0.70882428 |
175 | MP0005220_abnormal_exocrine_pancreas | 0.70841940 |
176 | MP0003936_abnormal_reproductive_system | 0.69804741 |
177 | MP0001984_abnormal_olfaction | 0.69658257 |
178 | MP0001873_stomach_inflammation | 0.68981704 |
179 | MP0010352_gastrointestinal_tract_polyps | 0.68973247 |
180 | MP0003453_abnormal_keratinocyte_physiol | 0.68792602 |
181 | MP0001145_abnormal_male_reproductive | 0.66098435 |
182 | MP0002080_prenatal_lethality | 0.65981638 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Interstitial pulmonary disease (HP:0006530) | 8.44442636 |
2 | Gout (HP:0001997) | 6.45110669 |
3 | Recurrent gram-negative bacterial infections (HP:0005420) | 5.03649779 |
4 | Recurrent abscess formation (HP:0002722) | 4.96563131 |
5 | Eczematoid dermatitis (HP:0000976) | 4.95113542 |
6 | Recurrent bacterial skin infections (HP:0005406) | 4.88018608 |
7 | Optic neuritis (HP:0100653) | 4.62150107 |
8 | Retrobulbar optic neuritis (HP:0100654) | 4.62150107 |
9 | Myositis (HP:0100614) | 4.55797128 |
10 | Orchitis (HP:0100796) | 4.46866929 |
11 | Shawl scrotum (HP:0000049) | 4.11958746 |
12 | Breast hypoplasia (HP:0003187) | 4.11496874 |
13 | Gastrointestinal infarctions (HP:0005244) | 4.10014098 |
14 | Tubulointerstitial fibrosis (HP:0005576) | 4.02150106 |
15 | Hyperactive renin-angiotensin system (HP:0000841) | 3.96583017 |
16 | Deep venous thrombosis (HP:0002625) | 3.96175588 |
17 | Tachypnea (HP:0002789) | 3.86822902 |
18 | Gingival bleeding (HP:0000225) | 3.79030952 |
19 | Renal salt wasting (HP:0000127) | 3.77986713 |
20 | Abnormality of cochlea (HP:0000375) | 3.73417429 |
21 | Recurrent skin infections (HP:0001581) | 3.58916688 |
22 | Abnormality of the labia minora (HP:0012880) | 3.56710776 |
23 | Hypokalemic alkalosis (HP:0001949) | 3.56165767 |
24 | Increased circulating renin level (HP:0000848) | 3.53900511 |
25 | Stomatitis (HP:0010280) | 3.50338194 |
26 | Chronic bronchitis (HP:0004469) | 3.41864676 |
27 | Keratoconjunctivitis sicca (HP:0001097) | 3.41079961 |
28 | Prolonged partial thromboplastin time (HP:0003645) | 3.39352014 |
29 | T lymphocytopenia (HP:0005403) | 3.37691012 |
30 | Recurrent fungal infections (HP:0002841) | 3.35090720 |
31 | Abnormality of T cell number (HP:0011839) | 3.32929744 |
32 | Respiratory distress (HP:0002098) | 3.27404572 |
33 | Hyperglycinuria (HP:0003108) | 3.22073970 |
34 | Hyperglycinemia (HP:0002154) | 3.20870575 |
35 | Keratoconjunctivitis (HP:0001096) | 3.15765666 |
36 | Ulnar bowing (HP:0003031) | 3.15552924 |
37 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.14903201 |
38 | Recurrent cutaneous fungal infections (HP:0011370) | 3.14451761 |
39 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.14451761 |
40 | Hypochromic microcytic anemia (HP:0004840) | 3.13898089 |
41 | Encephalitis (HP:0002383) | 3.12999256 |
42 | Metabolic alkalosis (HP:0200114) | 3.11653715 |
43 | Prolonged bleeding time (HP:0003010) | 3.11032232 |
44 | Hyperuricemia (HP:0002149) | 3.10290704 |
45 | Increased purine levels (HP:0004368) | 3.10290704 |
46 | Abnormality of the common coagulation pathway (HP:0010990) | 3.03317262 |
47 | Onycholysis (HP:0001806) | 3.01394898 |
48 | Tubulointerstitial nephritis (HP:0001970) | 3.00715607 |
49 | Stomach cancer (HP:0012126) | 2.99944865 |
50 | Pustule (HP:0200039) | 2.98952620 |
51 | Abnormality of the distal phalanges of the toes (HP:0010182) | 2.97305960 |
52 | Meningitis (HP:0001287) | 2.96128345 |
53 | Stenosis of the external auditory canal (HP:0000402) | 2.94375897 |
54 | Arterial thrombosis (HP:0004420) | 2.94173780 |
55 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.92828396 |
56 | Chronic obstructive pulmonary disease (HP:0006510) | 2.91371097 |
57 | Obstructive lung disease (HP:0006536) | 2.91371097 |
58 | Hypomagnesemia (HP:0002917) | 2.90491156 |
59 | Pulmonary embolism (HP:0002204) | 2.90466880 |
60 | Joint hemorrhage (HP:0005261) | 2.86416765 |
61 | Epistaxis (HP:0000421) | 2.85772910 |
62 | Hypochromic anemia (HP:0001931) | 2.83505521 |
63 | Spontaneous hematomas (HP:0007420) | 2.83435469 |
64 | Gingivitis (HP:0000230) | 2.82735587 |
65 | Sparse lateral eyebrow (HP:0005338) | 2.81809510 |
66 | Mediastinal lymphadenopathy (HP:0100721) | 2.77818402 |
67 | Vasculitis (HP:0002633) | 2.75521791 |
68 | Morphological abnormality of the inner ear (HP:0011390) | 2.73327161 |
69 | Anorexia (HP:0002039) | 2.70683421 |
70 | Peritonitis (HP:0002586) | 2.69487203 |
71 | Aplasia involving bones of the extremities (HP:0009825) | 2.67439422 |
72 | Aplasia involving bones of the upper limbs (HP:0009823) | 2.67439422 |
73 | Aplasia of the phalanges of the hand (HP:0009802) | 2.67439422 |
74 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.61203450 |
75 | Osteolytic defects of the hand bones (HP:0009699) | 2.61203450 |
76 | Thrombophlebitis (HP:0004418) | 2.60048993 |
77 | Gangrene (HP:0100758) | 2.59677682 |
78 | Abnormality of chloride homeostasis (HP:0011422) | 2.58358560 |
79 | Hemoptysis (HP:0002105) | 2.55989537 |
80 | Aplasia/Hypoplasia of the phalanges of the toes (HP:0010173) | 2.53946677 |
81 | Abnormality of the umbilical cord (HP:0010881) | 2.51963879 |
82 | Tubulointerstitial abnormality (HP:0001969) | 2.51007817 |
83 | Carpal bone hypoplasia (HP:0001498) | 2.49448536 |
84 | Hypoplastic nipples (HP:0002557) | 2.48659982 |
85 | Breast carcinoma (HP:0003002) | 2.48495126 |
86 | Prolonged neonatal jaundice (HP:0006579) | 2.48078569 |
87 | Abnormality of the 2nd finger (HP:0004100) | 2.47619810 |
88 | Chest pain (HP:0100749) | 2.45701016 |
89 | Short nail (HP:0001799) | 2.44288583 |
90 | Hypoplastic labia majora (HP:0000059) | 2.43782280 |
91 | Tetany (HP:0001281) | 2.43637749 |
92 | Abnormality of the phalanges of the 2nd finger (HP:0009541) | 2.42955269 |
93 | Menorrhagia (HP:0000132) | 2.41064757 |
94 | Abnormality of T cells (HP:0002843) | 2.40069298 |
95 | Urticaria (HP:0001025) | 2.39169124 |
96 | Aplasia/Hypoplasia of the ulna (HP:0006495) | 2.39121234 |
97 | Absent radius (HP:0003974) | 2.39027191 |
98 | Abnormality of glycine metabolism (HP:0010895) | 2.37680084 |
99 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.37680084 |
100 | Hypoplasia of the ulna (HP:0003022) | 2.36596576 |
101 | Acute hepatic failure (HP:0006554) | 2.36308205 |
102 | Facial shape deformation (HP:0011334) | 2.33734230 |
103 | Potter facies (HP:0002009) | 2.33734230 |
104 | Amyloidosis (HP:0011034) | 2.33170161 |
105 | Abnormal platelet volume (HP:0011876) | 2.32977280 |
106 | Abnormality of the proximal phalanges of the hand (HP:0009834) | 2.30374150 |
107 | Aplasia/Hypoplasia of the 1st metacarpal (HP:0010026) | 2.29671573 |
108 | Short 1st metacarpal (HP:0010034) | 2.29671573 |
109 | Pulmonary infiltrates (HP:0002113) | 2.29258498 |
110 | Impulsivity (HP:0100710) | 2.26970266 |
111 | Episodic fever (HP:0001954) | 2.26939939 |
112 | Hypobetalipoproteinemia (HP:0003563) | 2.25489296 |
113 | Congenital, generalized hypertrichosis (HP:0004540) | 2.25205905 |
114 | Abnormality of the middle phalanges of the toes (HP:0010183) | 2.23535486 |
115 | Subcapsular cataract (HP:0000523) | 2.23050280 |
116 | Leukocytosis (HP:0001974) | 2.20999978 |
117 | Absent hand (HP:0004050) | 2.19675657 |
118 | Abnormality of purine metabolism (HP:0004352) | 2.19618839 |
119 | Broad distal phalanx of finger (HP:0009836) | 2.19056326 |
120 | Aplasia involving forearm bones (HP:0009822) | 2.19043359 |
121 | Absent forearm bone (HP:0003953) | 2.19043359 |
122 | Glucose intolerance (HP:0000833) | 2.18511151 |
123 | Bowing of the arm (HP:0006488) | 2.15792188 |
124 | Bowed forearm bones (HP:0003956) | 2.15792188 |
125 | Abnormality of the labia majora (HP:0012881) | 2.15028198 |
126 | Aplasia/Hypoplasia of the hallux (HP:0008362) | 2.14964933 |
127 | Papillary thyroid carcinoma (HP:0002895) | 2.14181351 |
128 | Polyuria (HP:0000103) | 2.11136019 |
129 | Aplasia/Hypoplasia of the patella (HP:0006498) | 2.09537760 |
130 | Abnormality of the fingertips (HP:0001211) | 2.08906639 |
131 | Long toe (HP:0010511) | 2.08499682 |
132 | Short humerus (HP:0005792) | 2.07995654 |
133 | Systemic lupus erythematosus (HP:0002725) | 2.07110296 |
134 | Ureteral duplication (HP:0000073) | 2.06973220 |
135 | Purpura (HP:0000979) | 2.06900576 |
136 | Osteomalacia (HP:0002749) | 2.06588155 |
137 | Aplasia/hypoplasia of the humerus (HP:0006507) | 2.06304111 |
138 | Subacute progressive viral hepatitis (HP:0006572) | 2.04492459 |
139 | Hypoplastic scapulae (HP:0000882) | 2.04409737 |
140 | Aplasia/Hypoplasia of the scapulae (HP:0006713) | 2.04409737 |
141 | Abnormality of the pleura (HP:0002103) | 2.03585494 |
142 | Recurrent viral infections (HP:0004429) | 2.02298194 |
143 | Abnormality of the peritoneum (HP:0002585) | 2.02186384 |
144 | Abnormal urine output (HP:0012590) | 2.01803414 |
145 | Short hallux (HP:0010109) | 2.01565434 |
146 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.00998276 |
147 | Male infertility (HP:0003251) | 2.00237465 |
148 | Stillbirth (HP:0003826) | 2.00032412 |
149 | Split foot (HP:0001839) | 1.99926471 |
150 | Abnormality of the 1st metacarpal (HP:0010009) | 1.99881657 |
151 | Lip pit (HP:0100267) | 1.98458473 |
152 | Joint swelling (HP:0001386) | 1.97402346 |
153 | Anal stenosis (HP:0002025) | 1.97068880 |
154 | Breast aplasia (HP:0100783) | 1.95865172 |
155 | Osteomyelitis (HP:0002754) | 1.94947362 |
156 | Myocardial infarction (HP:0001658) | 1.94528519 |
157 | Aplasia of the musculature (HP:0100854) | 1.92236023 |
158 | Facial hemangioma (HP:0000329) | 1.92218584 |
159 | Short clavicles (HP:0000894) | 1.92133754 |
160 | Hypotension (HP:0002615) | 1.91099013 |
161 | Hematochezia (HP:0002573) | 1.91047631 |
162 | Patellar aplasia (HP:0006443) | 1.90269867 |
163 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.90098671 |
164 | Recurrent sinusitis (HP:0011108) | 1.90009454 |
165 | Abnormality of renal excretion (HP:0011036) | 1.89776697 |
166 | Abnormality of T cell physiology (HP:0011840) | 1.89193691 |
167 | Hyperaldosteronism (HP:0000859) | 1.88292398 |
168 | Abnormality of magnesium homeostasis (HP:0004921) | 1.87605036 |
169 | Aplasia/Hypoplasia of the breasts (HP:0010311) | 1.87538419 |
170 | Increased mean platelet volume (HP:0011877) | 1.87001866 |
171 | Abnormality of the labia (HP:0000058) | 1.86591263 |
172 | Entropion (HP:0000621) | 1.86311693 |
173 | Glomerulonephritis (HP:0000099) | 1.86095838 |
174 | Spontaneous abortion (HP:0005268) | 1.85644328 |
175 | Acanthocytosis (HP:0001927) | 1.84981547 |
176 | Labial hypoplasia (HP:0000066) | 1.84549760 |
177 | Aplasia/Hypoplasia of the earlobes (HP:0009906) | 1.83736531 |
178 | Toxemia of pregnancy (HP:0100603) | 1.83279952 |
179 | Glomerulopathy (HP:0100820) | 1.82732016 |
180 | Hypoplastic female external genitalia (HP:0012815) | 1.81493736 |
181 | Abnormality of renin-angiotensin system (HP:0000847) | 1.81478343 |
182 | Biliary tract neoplasm (HP:0100574) | 1.80851789 |
183 | Ankle contracture (HP:0006466) | 1.80636327 |
184 | Abnormality of macrophages (HP:0004311) | 1.79472541 |
185 | Autoimmune hemolytic anemia (HP:0001890) | 1.79238174 |
186 | Complement deficiency (HP:0004431) | 1.78862491 |
187 | Death in infancy (HP:0001522) | 1.78841628 |
188 | Rickets (HP:0002748) | 1.78137767 |
189 | Eosinophilia (HP:0001880) | 1.76642209 |
190 | Microcytic anemia (HP:0001935) | 1.75946673 |
191 | Viral hepatitis (HP:0006562) | 1.75303808 |
192 | Fibular aplasia (HP:0002990) | 1.72374504 |
193 | Abnormality of the axillary hair (HP:0100134) | 1.72211324 |
Rank | Gene Set | Z-score |
---|---|---|
1 | AKT3 | 6.97789668 |
2 | EPHA2 | 4.15671302 |
3 | RIPK4 | 4.11448309 |
4 | MST4 | 3.64024736 |
5 | BUB1 | 3.50180073 |
6 | STK24 | 3.03276494 |
7 | BLK | 2.88914477 |
8 | STK38L | 2.82539545 |
9 | TXK | 2.81628495 |
10 | FRK | 2.67114838 |
11 | LATS1 | 2.58691933 |
12 | WEE1 | 2.55879918 |
13 | CSK | 2.55381176 |
14 | TYK2 | 2.51693390 |
15 | IRAK4 | 2.34114784 |
16 | STK39 | 2.28570926 |
17 | PDK2 | 2.23237072 |
18 | OXSR1 | 2.22290885 |
19 | PLK4 | 2.21489270 |
20 | NEK1 | 2.15752797 |
21 | GRK6 | 2.15061361 |
22 | FGFR2 | 2.13179241 |
23 | MAP3K3 | 2.12018988 |
24 | MAP4K1 | 2.03639537 |
25 | NEK2 | 1.99723587 |
26 | FGFR3 | 1.89239949 |
27 | FGR | 1.85643399 |
28 | FES | 1.84248523 |
29 | YES1 | 1.83092427 |
30 | FGFR4 | 1.76508412 |
31 | STK10 | 1.75081360 |
32 | TAOK3 | 1.71067064 |
33 | BTK | 1.66191897 |
34 | MAP3K2 | 1.60224673 |
35 | LRRK2 | 1.60191171 |
36 | ERBB3 | 1.58992115 |
37 | TEC | 1.58417549 |
38 | PIK3CG | 1.57583066 |
39 | JAK3 | 1.51425130 |
40 | SYK | 1.51246969 |
41 | MAP3K14 | 1.50639237 |
42 | TSSK6 | 1.49775200 |
43 | STK3 | 1.47319736 |
44 | TTK | 1.42508317 |
45 | JAK2 | 1.42323593 |
46 | JAK1 | 1.40948726 |
47 | LATS2 | 1.36285621 |
48 | PINK1 | 1.35003800 |
49 | BRSK2 | 1.33202938 |
50 | PLK3 | 1.32963067 |
51 | ITK | 1.32885145 |
52 | ZAK | 1.28332676 |
53 | LYN | 1.27137679 |
54 | HCK | 1.26987040 |
55 | RPS6KB2 | 1.24255063 |
56 | WNK1 | 1.22874692 |
57 | IKBKE | 1.22704169 |
58 | MATK | 1.20926042 |
59 | MAP3K9 | 1.20085045 |
60 | NLK | 1.14995002 |
61 | IRAK1 | 1.11383994 |
62 | PDK3 | 1.10829462 |
63 | PDK4 | 1.10829462 |
64 | PRKCI | 1.06372085 |
65 | LCK | 1.04436522 |
66 | MYLK | 1.02922846 |
67 | CSF1R | 0.99636265 |
68 | PLK1 | 0.99601603 |
69 | TGFBR2 | 0.97926471 |
70 | CDK12 | 0.96364734 |
71 | MAP3K6 | 0.95436081 |
72 | CAMK1D | 0.95093538 |
73 | MARK3 | 0.91659027 |
74 | SGK223 | 0.90007366 |
75 | SGK494 | 0.90007366 |
76 | EIF2AK3 | 0.87257307 |
77 | LMTK2 | 0.85243818 |
78 | PAK4 | 0.85015965 |
79 | PDK1 | 0.84984557 |
80 | SIK3 | 0.82863597 |
81 | KSR2 | 0.82495559 |
82 | AURKA | 0.82300630 |
83 | MAPKAPK3 | 0.81150288 |
84 | PNCK | 0.79378988 |
85 | AURKB | 0.78680049 |
86 | GRK1 | 0.77815245 |
87 | RIPK1 | 0.77213874 |
88 | FER | 0.76713305 |
89 | BRD4 | 0.76408893 |
90 | MAP3K7 | 0.76191001 |
91 | PRKAA2 | 0.74671045 |
92 | EEF2K | 0.74275286 |
93 | EPHA3 | 0.71860770 |
94 | CAMK1G | 0.70242403 |
95 | MAP3K5 | 0.70125080 |
96 | MAP3K1 | 0.69895276 |
97 | PTK2B | 0.69089516 |
98 | MELK | 0.68806658 |
99 | PRKCQ | 0.68387448 |
100 | KIT | 0.67409840 |
101 | MAP3K8 | 0.66981067 |
102 | CHEK2 | 0.63977269 |
103 | STK38 | 0.63126466 |
104 | PIM1 | 0.62208571 |
105 | DYRK3 | 0.62007015 |
106 | ZAP70 | 0.61780121 |
107 | DAPK2 | 0.61016916 |
108 | SRPK1 | 0.59374723 |
109 | PIK3CA | 0.58292504 |
110 | STK11 | 0.57897605 |
111 | ARAF | 0.57613921 |
112 | MAP2K2 | 0.56669121 |
113 | MAP2K4 | 0.56047018 |
114 | BRSK1 | 0.55071385 |
115 | NUAK1 | 0.52900456 |
116 | ERBB2 | 0.52280109 |
117 | PRPF4B | 0.52237679 |
118 | SGK1 | 0.51827484 |
119 | TNK2 | 0.48964797 |
120 | TRPM7 | 0.48575796 |
121 | PDGFRB | 0.48389361 |
122 | FYN | 0.47780121 |
123 | TESK1 | 0.47580203 |
124 | MKNK2 | 0.47460600 |
125 | MARK2 | 0.47316898 |
126 | TAOK1 | 0.45738525 |
127 | MAP2K6 | 0.45159156 |
128 | ACVR1B | 0.44870065 |
129 | BCKDK | 0.44153206 |
130 | CSNK1G1 | 0.43846555 |
131 | CSNK1G2 | 0.43707540 |
132 | IRAK2 | 0.43147389 |
133 | RAF1 | 0.42901487 |
134 | IKBKB | 0.42860210 |
135 | WNK3 | 0.42242266 |
136 | CSNK1A1L | 0.40932160 |
137 | CDK6 | 0.40283218 |
138 | GSK3A | 0.40179405 |
139 | CAMK4 | 0.40107137 |
140 | BRAF | 0.39535899 |
141 | RET | 0.38417989 |
142 | TBK1 | 0.37276672 |
143 | CSNK1G3 | 0.36893158 |
144 | WNK4 | 0.36554938 |
145 | IGF1R | 0.36030317 |
146 | EGFR | 0.35992991 |
147 | PTK2 | 0.35866344 |
148 | STK4 | 0.35633729 |
149 | PDPK1 | 0.35322718 |
150 | PRKCZ | 0.34233714 |
151 | EPHB1 | 0.33677276 |
152 | PTK6 | 0.32888884 |
153 | DYRK1B | 0.31778077 |
154 | NEK6 | 0.31324588 |
155 | BMPR2 | 0.30614472 |
156 | TIE1 | 0.28809771 |
157 | SGK3 | 0.27555055 |
158 | ILK | 0.27086676 |
159 | RPS6KA4 | 0.26101842 |
160 | SGK2 | 0.25957968 |
161 | CDK7 | 0.25863889 |
162 | MAP3K12 | 0.25519126 |
163 | ALK | 0.24989924 |
164 | CHEK1 | 0.23365332 |
165 | EIF2AK1 | 0.23135630 |
166 | MAPK15 | 0.22990705 |
167 | MST1R | 0.21700448 |
168 | TTN | 0.21093386 |
169 | AKT2 | 0.20137281 |
170 | PRKAA1 | 0.20088934 |
171 | BCR | 0.19198066 |
172 | ERN1 | 0.19121591 |
173 | MAP2K3 | 0.19072795 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 5.87128048 |
2 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.47409244 |
3 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.93901522 |
4 | Mineral absorption_Homo sapiens_hsa04978 | 2.91222785 |
5 | Leishmaniasis_Homo sapiens_hsa05140 | 2.55654573 |
6 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 2.43456737 |
7 | RNA polymerase_Homo sapiens_hsa03020 | 2.32564237 |
8 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.27926962 |
9 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.23925677 |
10 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.21552395 |
11 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.16803647 |
12 | Regulation of autophagy_Homo sapiens_hsa04140 | 2.10459406 |
13 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.08529549 |
14 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 2.07192913 |
15 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 2.04476286 |
16 | Tight junction_Homo sapiens_hsa04530 | 2.03931661 |
17 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.96755929 |
18 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.94506893 |
19 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 1.87052336 |
20 | Tuberculosis_Homo sapiens_hsa05152 | 1.86790608 |
21 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.81204861 |
22 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.77046843 |
23 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.75574010 |
24 | Lysosome_Homo sapiens_hsa04142 | 1.75403657 |
25 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.70844210 |
26 | RNA transport_Homo sapiens_hsa03013 | 1.70705461 |
27 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.68182964 |
28 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.63111130 |
29 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.60557724 |
30 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.60312446 |
31 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.58450153 |
32 | Adherens junction_Homo sapiens_hsa04520 | 1.56719095 |
33 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.54568700 |
34 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.54464744 |
35 | Measles_Homo sapiens_hsa05162 | 1.53631003 |
36 | Legionellosis_Homo sapiens_hsa05134 | 1.51232316 |
37 | Cell cycle_Homo sapiens_hsa04110 | 1.51156263 |
38 | Hippo signaling pathway_Homo sapiens_hsa04390 | 1.47502851 |
39 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.46462238 |
40 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.45681015 |
41 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.44994279 |
42 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.43875193 |
43 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.42407943 |
44 | Malaria_Homo sapiens_hsa05144 | 1.42105043 |
45 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.38817470 |
46 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.37117544 |
47 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.36134889 |
48 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.34201055 |
49 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.33279509 |
50 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.32866371 |
51 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.31866618 |
52 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.31635609 |
53 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.30641377 |
54 | Sulfur relay system_Homo sapiens_hsa04122 | 1.29902455 |
55 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.29733886 |
56 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.25408584 |
57 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 1.24059687 |
58 | Histidine metabolism_Homo sapiens_hsa00340 | 1.20487126 |
59 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.17297019 |
60 | Allograft rejection_Homo sapiens_hsa05330 | 1.15888094 |
61 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.14658579 |
62 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 1.13992556 |
63 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.12721383 |
64 | Influenza A_Homo sapiens_hsa05164 | 1.12173860 |
65 | Platelet activation_Homo sapiens_hsa04611 | 1.10533250 |
66 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.09503364 |
67 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.08125864 |
68 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.07380108 |
69 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.07272267 |
70 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.06978797 |
71 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.06061298 |
72 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.05267837 |
73 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.03744131 |
74 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.99701655 |
75 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.98672380 |
76 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.97813083 |
77 | Bladder cancer_Homo sapiens_hsa05219 | 0.96633406 |
78 | Prostate cancer_Homo sapiens_hsa05215 | 0.96031068 |
79 | Circadian rhythm_Homo sapiens_hsa04710 | 0.95281610 |
80 | Other glycan degradation_Homo sapiens_hsa00511 | 0.93142902 |
81 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.93123481 |
82 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.92625480 |
83 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.92388481 |
84 | Phagosome_Homo sapiens_hsa04145 | 0.91990994 |
85 | Pertussis_Homo sapiens_hsa05133 | 0.91039653 |
86 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.90864095 |
87 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.90487435 |
88 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.90426480 |
89 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.90201038 |
90 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.87658162 |
91 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.87651992 |
92 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.84778004 |
93 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.84069026 |
94 | Endometrial cancer_Homo sapiens_hsa05213 | 0.83724996 |
95 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.81912166 |
96 | Hepatitis B_Homo sapiens_hsa05161 | 0.81537842 |
97 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.80739247 |
98 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.80288953 |
99 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.79631200 |
100 | Purine metabolism_Homo sapiens_hsa00230 | 0.78653832 |
101 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.77513009 |
102 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.76704204 |
103 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.75739287 |
104 | Hepatitis C_Homo sapiens_hsa05160 | 0.75400507 |
105 | Basal transcription factors_Homo sapiens_hsa03022 | 0.74022986 |
106 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.74019497 |
107 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.73102396 |
108 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.73065168 |
109 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.72262000 |
110 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.71858981 |
111 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.71460626 |
112 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.70003158 |
113 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.67138805 |
114 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.66806801 |
115 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.66789846 |
116 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.66722330 |
117 | Retinol metabolism_Homo sapiens_hsa00830 | 0.66034611 |
118 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.65197322 |
119 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.64724513 |
120 | Insulin resistance_Homo sapiens_hsa04931 | 0.64168111 |
121 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.63401247 |
122 | Thyroid cancer_Homo sapiens_hsa05216 | 0.63101282 |
123 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.63048881 |
124 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.62503664 |
125 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.62417415 |
126 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.61542400 |
127 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.59960411 |
128 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.59878552 |
129 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.59350715 |
130 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.56366980 |
131 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.55995923 |
132 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.54557435 |
133 | Peroxisome_Homo sapiens_hsa04146 | 0.54440125 |
134 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.54402967 |
135 | Proteasome_Homo sapiens_hsa03050 | 0.54222454 |
136 | Apoptosis_Homo sapiens_hsa04210 | 0.51760033 |
137 | Asthma_Homo sapiens_hsa05310 | 0.51283883 |
138 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.50953639 |
139 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.50376541 |
140 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.50362458 |
141 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.49673293 |
142 | Bile secretion_Homo sapiens_hsa04976 | 0.49653308 |
143 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.49627894 |
144 | Amoebiasis_Homo sapiens_hsa05146 | 0.48220470 |
145 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.47992741 |
146 | Viral myocarditis_Homo sapiens_hsa05416 | 0.47966092 |
147 | Pathways in cancer_Homo sapiens_hsa05200 | 0.47841321 |
148 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.47172623 |
149 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.46960995 |
150 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.45415863 |
151 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.44967978 |
152 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.44683411 |
153 | ABC transporters_Homo sapiens_hsa02010 | 0.44080215 |
154 | Melanoma_Homo sapiens_hsa05218 | 0.42263731 |
155 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.42166871 |
156 | Olfactory transduction_Homo sapiens_hsa04740 | 0.40203934 |
157 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.39433604 |
158 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.38088279 |
159 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.36966437 |
160 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.35925862 |
161 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.35456910 |
162 | Endocytosis_Homo sapiens_hsa04144 | 0.34853048 |
163 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.33510836 |
164 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.32580030 |
165 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.29661001 |
166 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.28573165 |
167 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.28349276 |
168 | Focal adhesion_Homo sapiens_hsa04510 | 0.28284357 |
169 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.27735407 |
170 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.27459081 |